BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ibidapo-Obe O, Stengel S, Köse-Vogel N, Quickert S, Reuken PA, Busch M, Bauer M, Stallmach A, Bruns T. Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation. Cell Mol Gastroenterol Hepatol 2020;9:661-77. [PMID: 31954178 DOI: 10.1016/j.jcmgh.2020.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Z, Wang H, Shi M, Zhu T, Pediongco T, Lim XY, Meehan BS, Nelson AG, Fairlie DP, Mak JYW, Eckle SBG, de Lima Moreira M, Tumpach C, Bramhall M, Williams CG, Lee HJ, Haque A, Evrard M, Rossjohn J, McCluskey J, Corbett AJ, Chen Z. Francisella tularensis induces Th1 like MAIT cells conferring protection against systemic and local infection. Nat Commun 2021;12:4355. [PMID: 34272362 DOI: 10.1038/s41467-021-24570-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kaminski H, Couzi L, Eberl M. Unconventional T cells and kidney disease. Nat Rev Nephrol 2021. [PMID: 34446934 DOI: 10.1038/s41581-021-00466-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Leeansyah E, Boulouis C, Kwa ALH, Sandberg JK. Emerging Role for MAIT Cells in Control of Antimicrobial Resistance. Trends Microbiol 2021;29:504-16. [PMID: 33353796 DOI: 10.1016/j.tim.2020.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sakai S, Lora NE, Kauffman KD, Dorosky DE, Oh S, Namasivayam S, Gomez F, Fleegle JD, Arlehamn CSL, Sette A, Sher A, Freeman GJ, Via LE, Barry Iii CE, Barber DL; Tuberculosis Imaging Program. Functional inactivation of pulmonary MAIT cells following 5-OP-RU treatment of non-human primates. Mucosal Immunol 2021;14:1055-66. [PMID: 34158594 DOI: 10.1038/s41385-021-00425-3] [Reference Citation Analysis]
5 Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, Álvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34703031 DOI: 10.1038/s41575-021-00520-7] [Reference Citation Analysis]
6 Chuah JJM, Hertzog PJ, Campbell NK. Immunoregulation by type I interferons in the peritoneal cavity. J Leukoc Biol 2021. [PMID: 34612523 DOI: 10.1002/JLB.3MR0821-147R] [Reference Citation Analysis]
7 Marchant V, Tejera-Muñoz A, Marquez-Expósito L, Rayego-Mateos S, Rodrigues-Diez RR, Tejedor L, Santos-Sanchez L, Egido J, Ortiz A, Valdivielso JM, Fraser DJ, López-Cabrera M, Selgas R, Ruiz-Ortega M. IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis. Biomolecules 2020;10:E1361. [PMID: 32987705 DOI: 10.3390/biom10101361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]